Xtacy Therapeutics (XTCYF)
OTHER OTC:XTCYF
Holding XTCYF?
Track your performance easily

Xtacy Therapeutics (XTCYF) Income Statement

4 Followers

Xtacy Therapeutics Income Statement

Last quarter (Q1 2024), Xtacy Therapeutics's total revenue was C$―, a decrease of ― from the same quarter last year. In Q1, Xtacy Therapeutics's net income was C$-265.84K. See Xtacy Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Sep 23Sep 22Sep 21Sep 20Sep 19
Total Revenue
C$ 21.82KC$ 21.82K--C$ 101.87KC$ 112.28K
Cost of Revenue
---C$ 1.51KC$ 0.00-
Gross Profit
C$ 21.82KC$ 21.82K-C$ -1.51KC$ 101.87K-
Operating Expense
C$ 1.05MC$ 940.80KC$ 1.38MC$ 3.88MC$ 696.31KC$ 2.82M
Operating Income
C$ -1.03MC$ -918.98KC$ -1.38MC$ -3.88MC$ -594.44KC$ -2.71M
Net Non Operating Interest Income Expense
C$ -5.28K-C$ -4.59KC$ 1.57KC$ -1.95KC$ -2.62K
Other Income Expense
C$ -437.10KC$ -401.33KC$ -11.43KC$ 298.05KC$ -778.60KC$ 338.14K
Pretax Income
C$ -597.41KC$ -519.94KC$ -1.37MC$ -3.58MC$ -1.37MC$ -2.37M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ -597.41KC$ -519.94KC$ -1.37MC$ -3.58MC$ -1.37MC$ -2.37M
Basic EPS
C$ -0.02C$ -0.01C$ -0.05C$ -0.23C$ -0.10C$ -0.20
Diluted EPS
C$ -0.02C$ -0.01C$ -0.05C$ -0.23C$ -0.10C$ -0.20
Basic Average Shares
C$ 189.56MC$ 43.55MC$ 27.15MC$ 15.87MC$ 13.83MC$ 12.12M
Diluted Average Shares
C$ 189.56MC$ 43.55MC$ 27.15MC$ 15.87MC$ 13.83MC$ 12.12M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
-----C$ 7.19K
Total Expenses
C$ 1.05MC$ 940.80KC$ 1.38M-C$ 696.31KC$ 2.82M
Interest Expense
-----C$ 2.62K
Net Income From Continuing And Discontinued Operation
C$ -597.41KC$ -519.94KC$ -1.37MC$ -3.58MC$ -1.37MC$ -2.37M
Normalized Income
C$ -506.88KC$ -382.15KC$ -1.01MC$ -2.93MC$ -526.68KC$ -2.44M
EBIT
C$ -594.07KC$ -517.65KC$ -1.36MC$ -3.58MC$ -594.44KC$ -2.71M
EBITDA
C$ -594.07KC$ -517.65KC$ -1.36MC$ -3.58MC$ -594.44KC$ -2.71M
Currency in CAD

Xtacy Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis